Agamree (vamorolone) will be Covered in Slovenia by the Slovenian Health Insurance Fund
The Slovenian Health Insurance Institute (ZZZS) today added Agamree (vamorolone) to the list of drugs for the treatment of Duchenne muscular dystrophy in patients...
Russia-Based Circle of Kindness Foundation Announces 18% Price Cut for Elevidys Gene Therapy
According to the Foundation's press office, "as a result of the negotiations, the price of one of the most expensive drugs (Elevidys) in the...
Belief BioMed BBM-D101 Gene Therapy Receives IND Clearance by National Medical Products Administration (NMPA)
Belief BioMed (BBM), an innovative biotechnology company focused on developing cutting-edge gene therapies, today announced that it has received National Medical Products Administration (NMPA)...
New Drug Submission for AGAMREE (vamorolone) Accepted for Priority Review by Health Canada for the Treatment of Duchenne Muscular Dystrophy
Catalyst Pharmaceuticals has announced that Health Canada has accepted their New Drug Submission (NDS) for AGAMREE (vamorolone) with priority review status for treating Duchenne...
Genethon CEO Frederic Revah Announces GNT0004 Gene Therapy Will Provide Amazing Results for DMD (Duchenne Muscular Dystrophy)
The Chief Executive Officer of Genethon, Frederic Revah, made the announcement on the YouTube channel of AFM-Telethon that the GNT0004 gene therapy, which is...